Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Arnott, Janine ^a   Hesselgreaves, Hannah ^a   Nunn, Anthony J ^b   Peak, Matthew ^b   Pirmohamed, Munir ^a   Smyth, Rosalind L ^a   Turner, Mark A ^c   Young, Bridget ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL STIMULANT AGENT; CORTICOSTEROID; IMMUNOLOGIC AGENT; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; RESPIRATORY TRACT AGENT; VACCINE;

ADULT; ADVERSE DRUG REACTION; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CHILD; DOCTOR PATIENT RELATION; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; DRUG USE; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE SYSTEM; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; IMMUNOPATHOLOGY; INFECTION; INTERPERSONAL COMMUNICATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MUCOSAL DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PARENT; PARENTAL ATTITUDE; PATIENT ABANDONMENT; PERSONAL EXPERIENCE; PHYSICIAN ATTITUDE; PRESCHOOL CHILD; QUALITATIVE RESEARCH; RESPIRATORY TRACT DISEASE; SATISFACTION; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SKIN DISEASE; UNITED KINGDOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNICATION; DRUG THERAPY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PARENTS; PROFESSIONAL-FAMILY RELATIONS;

EID: 84867377682     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046022     Document Type: Article

References (84)

1. Edwards IR, Aronson JK, (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356: 1255-1259.
2. World Health Organisation (2008) Medicines: safety of medicines - adverse drug reactions. Media Centre. Fact sheet N°293 ed.
3. MHRA (2010) Healthcare professional reporting: Adverse drug reactions. http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Reportingsuspectedadversedrugreactions/Healthcareprofessionalreporting/index.htm. Accessed 2012.
4. Avery A, Anderson C, Bond C, Fortnum H, Gifford A, (2011) Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess 2011; 15 (20).
5. Fortnum H, Lee AJ, Rupnik B, Avery A, (2011) Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain. Br J Clin Pharmacol Ther 37 (2):: 161-165.
6. European Medicines Agency (2009) Information on benefits and risks of medicines: Patients' consumers' and healthcare professionals' expectations. London: European Medicines Agency (EMA).
7. Akobeng AK, (2008) Communicating the benefits and harms of treatments. Arch Dis Child 93: 710-713.
8. Alaszewski A, (2005) A person-centre appraoch to communicating risk. PLoS Med 2 (2):: e41 doi:10.1371/journal.pmed.0020041.
9. Berry DC, (2004) Interpreting information about medication side effects: Differences in risk perception and intention to comply when medicines are prescribed for adults or young children. Psychol Health Med 9: 227-234.
10. European Medicines Agency (2010) The European Medicines Agency Road Map to 2015: The agency's contribution to science, medicine and health. European Medicine Agency (EMA).
11. Godolphin W, (2003) The role of risk communication in shared decision making. BMJ 327: 692-693.
12. Berry DC, Raynor DK, Knapp P, (2003) Communicating risk of medication side effects: an empirical evaluation of EU recommended terminology. Psychol Health Med 8: 251-63.
13. Politi MC, Han PKJ, Col NF, (2007) Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making 27: 681-695.
14. Berry DC, Michas IC, Bersellini E, (2003) Communicating information about medication: The benefits of making it personal. Psychol Health 18: 127-139.
15. Herxheimer A, (2005) Communicating with patients about harms and risks. Plos Med 2: 91-92.
16. Hugman B, Edwards IR, (2006) The challenge of effectively communicating pateint safety information. Expert Opinion. Drug Saf 5: 495-499.
17. Franic DM, Pathak DS, (2000) Communicating the frequency of adverse drug reactions to female patients. Drug Information Journal 34: 251-251.
18. Tarn DM, Paterniti DA, Williams BR, Cipri CS, Wenger NS, (2009) Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives. J Am Geriatr Soc 57: 462-469.
19. Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H, et al. (2012) The perceived sensitivity to medicines (PSM) scale: An evaluation of validity and reliability. Brit Journal Health Psych doi: 10.1111/j.2044-8287.2012.02071.
20. Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ, (2010) Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthrit Care Res 62: 791-799.
21. Pound P, Britten N, Morgan M, Yardley L, Pope C, et al. (2005) Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 61: 133-155.
22. Britten N, (1994) Patients' ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract 44: 465-468.
23. Horne R, Weinman J, (1999) Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47: 555-567.
24. Stevenson FA, Gerrett D, Rivers P, Wallace G, (2000) GPs' recognition of, and response to, influences on patients' medicine taking: the implications for communication. Fam Pract 17: 119-123.
25. Horne R, Parham R, Driscoll R, Robinson A, (2009) Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflammatory Bowel Diseases 15: 837-844.
26. Horne R (1997) Representations of medication and treatment: advances in theory and measurement. In: Petrie K, Weinman J, editors. Perceptions of Health and Illness: Current research and applications. London: Harwood Academic Publishers.
27. Nestoriuc Y, Glombiewski JA, Glaesmer H, Horne R, Braehler E, et al. (2010) Does the way we think about medications determine how we use them? Validation of the beliefs about medicines questionnaire in the general population in Germany. Int J Behav Med 17: 79-79.
28. Ball LK, Evans G, Bostrom A, (1998) Risky Business: Challenges in vaccine risk communication. Pediatrics 101: 453-458.
29. Bellaby P, (2003) Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination. BMJ 327: 725-728.
30. Gust DA, Darling N, Kennedy A, Schwartz B, (2008) Parents With doubts about vaccines: Which vaccines and reasons why. Pediatrics 122: 718-725.
31. Hobson-West P, (2003) Understanding vaccination resistance: moving beyond risk. Health Risk Soc 5 (3):: 273-283.
32. Mills E, Jadad AR, Ross C, Wilson K, (2005) Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol 58: 1081-1088.
33. Bellaire J, Speechley KN, Seabrook JA, Rieder MJ, Matsui D, (2005) Health-related qualitaty of life among children who have had adverse drug reactions. Paediatr Perinat Drug Ther 6 (4):: 186-191.
34. Lorimer S, Cox A, Langford NJ, (2011) A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting. J Clin Pharm Ther 37: 148-152.
35. Mukattash TL, Millership JS, Collier PS, McElnay JC, (2008) Public awareness and views on unlicensed use of medicines in children. Brit J Clin Pharmaco 66: 838-845.
36. t Jong GW, Stricker BHC, Choonara I, van den Anker JN, (2002) Lack of effect of the European guidance on clinical investigation of medicines in children. Acta Paediatrica 91: 1233-1238.
37. Yoon EY, Clark SJ, Butchart A, Singer D, Davis MM, (2011) Parental preferences for FDA-approved medications prescribed for their children. Clin Pediatr 50: 208-214.
38. Grinyer A, (2004) Young adults with cancer: parents' interactions with health care professionals. Eur J Cancer Care 13: 88-95.
39. Kai J, (1996) What worries parents when their preschool children are acutely ill, and why: A qualitative study. BMJ 313: 983-986.
40. Naranjo C, Busto U, Sellers EM, (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245.
41. Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P, (1998) Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess 2 (16).
42. Patton MQ, (1999) Enhancing the quality and credibility of qualitative analysis. Health Serv Res 34: 1189-1208.
43. Patton MQ (2002) Qualitative research and evaluation methods. London: Sage Publications.
44. ADRIC (2012) http://www.adric.org.uk/Index.html.
45. Bowen GA, (2008) Naturalistic inquiry and the saturation concept: a research note. Qualitative Research 8 (1):: 137-152.
46. Barbour R, (2001) Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ 322: 1115-1117.
47. Sandelowski M, (2000) Whatever happened to qualitative description? Res Nurs Health 23 (4):: 334-40.
48. Stige B, Malterud K, Midtgarden T, (2009) Toward an agenda for evaluation of qualitative research. Qual Health Res 19: 1504-1516.
49. Chamberlain K, (2000) Methodolatry and qualitative health research. J Health Psychol 5: 285.
50. Boeije H (2010) Analysis in qualitative research. London: Sage Publications Ltd.
51. Bryman A, Burgess R (2004) Analyzing qualitative data. London: Routledge.
52. Charmaz K (2003) Grounded theory. Objectivist and constructivist methods. In: Denzin NK, Lincoln YS, editors. Strategies of Qualitative Inquiry. London: Sage Publications.
53. Glaser BG, Strauss A (1967) Discovery of grounded theory. Strategies for Qualitative Research. Chicago, Aldine Publishing Co.
54. Strauss A, Corbin C (1998) Basics of qualitative research. London: Thousand Oaks, CA Sage Publictions Ltd.
55. Stiles WB, (1999) Evaluating qualitative research. EBMH 2: 99-101.
56. Salmon P, Peters S, Rogers A, Gask L, Clifford R, et al. (2007) Peering through the barriers in GPs' explanations for declining to participate in research: the role of professional autonomy and the economy of time. Family Practice 24: 269-275.
57. Bevir M, Rhodes R (2002) Interpretative theory. In: Marsh D, Stoker G, editors. Theory and methods in political science. London: Palgrave MacMillan.
58. Bryman A, Burgess R (2004) Analyzing Qualitative Data. London: Routledge.
59. Lincoln YS, Guba EG, editors (2003) Paradigmatic controversies, contradiction and emerging confluences in The landscape of qualitative research. London: Sage Publications.
60. Fossey E, Harvey C, McDermott F, Davidson L, (2002) Understanding and evaluating qualitative research. Aust NZ J Psychiat 36: 717-732.
61. Pope C, Ziebland S, Mays N, (2000) Analysing qualitative data. BMJ 320.
62. Lincoln YS, Guba EG (1985) Naturalistic inquiry. Newbury Park CA: Sage.
63. Walker D, Myrick F, (2006) Grounded theory: An exploration of process and procedure. Qual Health Res 16: 547-559.
64. La Pelle N, (2004) Simplifying qualitative data analysis using general purpose software tools. Field Method 16: 85-108.
65. Hammersely M (1992) Social research. Philosophy, politics and practice. London: Sage.
66. Denzin NK (1970) The research act in sociology. Chicago: Aldine.
67. Janesick V (1994) The dance of qualitative research design: Methaphor, methodolatory and meaning. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Thousand Oaks CA: Sage.
68. Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, et al. (2011) Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One 6: e28096.
69. Britten N, (1994) Patients' ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract 44 (387):: 465-468.
70. Leickly FE, Wade SL, Crain E, Kruszon-Moran D, Wright EC, et al. (1998) Self-reported adherence, management behavior, and barriers to care after an emergency department visit by inner city children with asthma. Pediatrics 101: e8-e8.
71. Duclos CW, Eichler M, Taylor L, Quintela J, Main DS, et al. (2005) Patient perspectives of patient-provider communication after adverse events. Int J Qual Health C 17 (6):: 479-486.
72. Gallagher TH, Studdert D, Levinson W, (2007) Disclosing harmful medical errors to patients. N Engl J Med 356 (26):: 2713-2719.
73. Levetown M, (2008) the Committee on Bioethics (2008) Communicating with children and families: From everyday interactions to skill in conveying distressing Information. Pediatrics 121: e1441-e1460.
74. Loren DJ, Klein EJ, Garbutt J, Krauss MJ, Fraser V, et al. (2008) Medical error disclosure among pediatricians. Arch Pediatr Adolesc Med 162: 922-927.
75. Mazor KM, Goff SL, Dodd KS, Velten SJ, Walsh KE, (2010) Parents' perceptions of medical errors. J Patient Saf 6 (2):: 102-107.
76. Mazor KM, Simon SR, Gurwitz JH, (2004) Communicating with patients about medical errors- A review of the literature. Arch Internal Med 164 (15):: 1690-1697.
77. National Patient Safety A (2009) Being open: Communicating patient safety incidents with patients, their families and carers. National Patient Safety Agency. (NPSA/2009/PSA003).
78. Vincent C, (2003) Understanding and responding to adverse events. N Engl J Med 348 (11):: 1051-1056.
79. Yardley IE, Yardley SJ, Wu AW, (2010) How to discuss errors and adverse events with cancer patients. Curr Oncol Rep 10: 253-260.
80. Garbutt J, Brownstein DR, Klein EJ, Waterman A, Krauss MJ, et al. (2007) Reporting and disclosing medical errors- Pediatricians' attitudes and behaviors. Arch Pediatr Adolesc Med 161: 179-185.
81. Kaldjian LC, Jones EW, Tripp-Reimer T, Hillis SL, Rosenthal GE, (2004) An empirically derived taxonomy of factors affecting physicians' willingness to disclose medical errors. J Gen Intern Med 19: 117.
82. Salmon P, (2007) Conflict, collusion or collaboration in consultations about medically unexplained symptoms: The need for a curriculum of medical explanation. Patient Educ Couns 67 (3):: 246-254.
83. Agbabiaka TB, Savovi J, Ernst E, (2008) Methods for causality assessment of adverse drug reactions: A systematic review. Drug Saf 31 (1):: 21-37.
84. Hartwig SC, Siegel J, Schneider PJ, (1992) Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49: 2229-2232.